Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Kate

Kate Barteau, Goleta, CA US

Patent application numberDescriptionPublished
20120326073POLYMER ELECTROLYTES BASED ON POLY(GLYCIDYL ETHER)S - A polymer electrolyte composition including a metal salt and at least one polymer comprising a poly(glycidyl ether), where the at least one polymer is amorphous at ambient temperature. The poly(glycidyl ether) polymer can be a blend of poly(glycidyl ether) polymers, can be a poly(glycidyl ether) polymer blended with a mechanically strong solid polymer, and can be a block of a block copolymer that also includes a polymer block forming a mechanically strong solid polymer.12-27-2012

Kate Byth, Waltham, MA US

Patent application numberDescriptionPublished
20090312396METHODS FOR CANCER TREATMENT USING TAK1 INHIBITORS - The invention includes, in part, a method of inhibiting lymphoid tumour cell proliferation by contacting the lymphoid with a TAK1 inhibitor.12-17-2009

Kate Chen, Corinth, TX US

Patent application numberDescriptionPublished
20080275718KNOCK DOWN CHAIR - An auditorium chair comprised essentially of four parts that interconnect creating a frame with a three point stability system. The auditorium chair structure has the following components: fastening with screws, snap tight buttons, or other fasteners, dimensioning in accordance with use in current auditorium chair sizes, and fabrication design enabling efficient shipment while maintaining stability and stacking capability.11-06-2008
20110057499HINGE ASSEMBLY FOR BOAT SEAT - An embodiment of a hinge assembly includes a seat back support, a seat bottom support, a hinge pivot, and a stop pin. The seat back support has a seat back mounting portion and a seat back hinge portion. The seat back hinge portion includes a stop notch formed at an end of the seat back hinge portion. The seat bottom support has a seat bottom mounting portion and a seat bottom hinge portion. The hinge pivot passes through the seat back hinge portion and the seat bottom hinge portion to hingedly couple the seat back hinge portion to the seat bottom portion. The stop pin has a stop pin shaft and a stop pin head positioned at a first end of the stop pin shaft. A second end of the stop pin shaft is affixed to the seat bottom hinge portion of the seat bottom support proximate to the seat back hinge portion of the seat back support.03-10-2011

Kate Corish, Raheen IE

Patent application numberDescriptionPublished
20120035717Catheter Assembly with Valve Crimping Accessories - Valve delivery catheter assemblies including components that limit trauma to the expanded prosthetic valve and body channels as the distal tip of the catheter is withdrawn through the expanded valve and thereafter from the body. In one embodiment, a catheter assembly according to the present invention includes a handle assembly, an introducer sheath, and a distal tip assembly. The handle assembly can include a fixed main handle and two or more rotating handles that allow a user to control the distal tip assembly of the catheter. A valve retaining mechanism can be included to assist in retaining the prosthetic valve prior to deployment. Each control knob on the handle assembly controls a portion of the components on the distal tip of the catheter by allowing for precise manipulation of various delivery shafts. Each delivery shaft extends from the handle assembly to respective positions towards the distal end of the catheter.02-09-2012
20120041547Heart Valve Delivery Catheter With Safety Button - Valve delivery catheter assemblies including components that limit trauma to the expanded prosthetic valve and body channels as the distal tip of the catheter is withdrawn through the expanded valve and thereafter from the body. Catheter assemblies according to the present invention can include a handle assembly, an introducer sheath, and a distal tip assembly. The handle assembly can include a fixed main handle and two or more rotating handles that allow a user to control the distal tip assembly of the catheter. A safety button can be included on the handle assembly to allow for precise and consistent positioning of the prosthetic valve in the body. A valve retaining mechanism can be included to assist in retaining the prosthetic valve prior to deployment.02-16-2012

Kate Grinney, New York, NY US

Patent application numberDescriptionPublished
20090171743SERVICE REQUEST SYSTEM WITH NATURAL SERVICE PROVIDER PROFILING AND METHODS THEREOF - A system and method for managing service requests performs the steps of loading profile settings for service providers, where the profile settings comprise a two dimensional matrix of actions and objects, processing a work order by determining task involved in the accomplishment of the work order, mapping the profile settings into a hierarchy of determined tasks of the work order and providing a listing of service providers for the work order through results of the mapping step.07-02-2009

Kate Heddleston, San Francisco, CA US

Patent application numberDescriptionPublished
20130031176IDENTIFICATION OF ROGUE SOCIAL MEDIA ASSETS - Identification of rogue social media assets is provided. In some embodiments, identification of rogue social media assets includes identifying a plurality of social media assets; comparing the plurality of social media assets with known social media assets to identify previously unknown social media assets; and displaying the identified previously unknown social media assets.01-31-2013

Kate Hoeganauer, Vienna AT

Patent application numberDescriptionPublished
20080306067Modulators of Chemokine Receptor Activity - A compound of formula (I), wherein substituents are as given above, useful in the treatment of a disease mediated by the action of CCR3, in particular inflammatory or obstructive airway diseases.12-11-2008

Kate Hoegenauer, Wien AT

Patent application numberDescriptionPublished
20080207718Use of Fused Imidazole Derivatives to Mediate Ccr3 Related Conditions - The use of compound of formula I in the preparation of a medicament, e.g. for the treatment of condition mediated by CCR3.08-28-2008

Kate Hsu, Taipei City TW

Patent application numberDescriptionPublished
20110054028SUPPLEMENT FOR REDUCING HIV TRANSMISSION AND METHOD THEREOF - There is an urgent need for a method to reduce the risk of mother-to-child transmission (MTCT) of HIV during breastfeeding in HIV pandemic regions. The present invention provides a supplement for reducing the chance of transmitting HIV during MTCT and method thereof. The supplement comprising arachidonic acid (AA) alone, or a mixture of AA and DHA at safe intake doses. The supplement is provided to either the breastfeeding mothers or the babies to maintain cell membrane potential polarization through activation of the background potassium channels, thereby reducing the risk of HIV transmission.03-03-2011

Kate Lagrand, Portland, OR US

Patent application numberDescriptionPublished
20110094128Personal Traction Device - Provided is a personal traction device that includes a traction mechanism that is very comfortable underfoot, while providing excellent traction over slippery surfaces as well as excellent long-term wear.04-28-2011
20120266501Personal Traction Device and Method of Making - Provided is a personal traction device that includes a traction mechanism that is very comfortable underfoot, while providing excellent traction over slippery surfaces as well as excellent long-term wear.10-25-2012

Kate Lyons Boyd, Encinitas, CA US

Patent application numberDescriptionPublished
20130023035REGULATION OF TOXIN AND ANTITOXIN GENES FOR BIOLOGICAL CONTAINMENT - The present invention relates to the regulation of a toxin and/or antitoxin genes in a genetically engineered microorganism, such as cyanobacterial or eukaryotic algal strains, in particular for preventing unintentional and/or uncontrolled spread of the microorganisms. The present invention also includes methods of controlling the growth and/or survival of the engineered microorganism01-24-2013

Kate Moloney-Egnatios, Los Altos, CA US

Patent application numberDescriptionPublished
20130024880WEB-BASED MUSIC PARTNER SYSTEMS AND METHODS - Systems and methods for media content development and deployment are disclosed. An example system includes a development platform and content delivery platform, the platforms including a processor and a memory. The example development platform is to provide an interface to accept media content from a provider to be certified for delivery via the delivery platform. The example development platform is to facilitate testing of the media content by the provider via the interface according to testing tools and an application programming interface provided in conjunction with the development platform. The example development platform is to process the media content for monitored beta test by users via the content delivery platform. The example development platform is to evaluate the monitored beta test to determine suitability of the media content for release. The example development platform is to facilitate release of the media content for general availability via the content delivery platform.01-24-2013

Kate Nuwaysir, Madison, WI US

Patent application numberDescriptionPublished
20110153222OPTIMIZED PROBE SELECTION METHOD - The present invention provides methods for optimizing oligonucleotide hybridization probes for use in basic and clinical research. Specifically, the invention involves hybridizing serially diluted genomic sample to the oligonucleotide probes on the array, such that a signal intensity is produced for each of the probes; computationally identifying optimized probes which exhibit signal intensities that correspond to the serial dilutions of genomic sample and are reproducibly strong relative to non-optimized probes.06-23-2011

Kate Rittenhouse-Olson, Williamsville, NY US

Patent application numberDescriptionPublished
20080226561THERAPEUTIC USE OF ANTI-TF-ANTIGEN ANTIBODY - The invention is related to administration of monoclonal antibody JAA-F11 to an individual for inhibition of metastasis and/or inhibition of growth of cells which express TF—Ag, or for detection of tumors or metastatic foci which express TF—Ag. For inhibition of metastasis or inhibition of growth of cells expressing TF—Ag, the method comprises administering to the individual a therapeutic amount of mAb JAA-F11, wherein the JAA-F11 mAb inhibits the metastasis and/or growth of the TF—Ag expressing cancer cells. For detection of tumors or metastatic foci, mAb JAA-F11 is conjugated to a detectable label and administered to the individual. Detection of the label identifies metastatic foci or tumors which comprise cancer cells expressing TF—Ag.09-18-2008

Patent applications by Kate Rittenhouse-Olson, Williamsville, NY US

Kate Tuson, Des Plaines, IL US

Patent application numberDescriptionPublished
20100222202TURNDOWN THERMOCOMPRESSOR DESIGN FOR CONTINUOUS CATALYST RECOVERY - Systems and processes for regenerating catalyst are provided herein that include a catalyst regeneration tower having a cooling zone that receives a catalyst cooling stream generated by a cooling gas loop. The systems and processes include a first thermocompressor that utilizes a first motive vapor and a second thermocompressor that utilizes a second motive vapor in order to provide the catalyst cooling stream to the regeneration tower. The second thermocompressor operates in parallel with the first thermocompressor. The first thermocompressor can utilize combustion air as the motive vapor. The second thermocompressor can utilize nitrogen as the motive vapor.09-02-2010
20120093699TURNDOWN THERMOCOMPRESSOR DESIGN FOR CONTINUOUS CATALYST RECOVERY - Systems and processes for regenerating catalyst are provided herein that include a catalyst regeneration tower having a cooling zone that receives a catalyst cooling stream generated by a cooling gas loop. The systems and processes include a first thermocompressor that utilizes a first motive vapor and a second thermocompressor that utilizes a second motive vapor in order to provide the catalyst cooling stream to the regeneration tower. The second thermocompressor operates in parallel with the first thermocompressor. The first thermocompressor can utilize combustion air as the motive vapor. The second thermocompressor can utilize nitrogen as the motive vapor.04-19-2012

Kate Wilson, Chiba JP

Patent application numberDescriptionPublished
20090081056Molecular Pump And Flange - To form a shock absorbing structure more easily.03-26-2009

Kate Wormington, San Carlos, CA US

Patent application numberDescriptionPublished
20090259502Quality-Based Media Management for Network-Based Media Distribution - Disclosed are techniques and configurations for monitoring quality of digital media assets available from a network-based media distribution system, and taking action to make those digital media assets that have quality deficiencies unavailable from the network-based media distribution system. The network-based media distribution system can provide an online media store from which users can acquire those of the digital media assets that are deemed available. In one embodiment, digital media assets that have quality deficiencies can be rapidly discovered and automatically removed from being available at an online media store.10-15-2009

Kate Zahir, Victoria CA

Patent application numberDescriptionPublished
20110109139NURSING CHAIR - A nursing chair may be sold as a kit comprising a first side panel, a second side panel, a front panel between said first and second side panel, a front fabric cover, a back fabric cover, a first side armrest, a second side armrest, a seat between the first and second side panel, a back rest between the first and second side panels and a rocker assembly for supporting said chair and imparting a rocking motion to the chair. Suitable fastening means are included in the kit. The chair may be sold assembled.05-12-2011